New Year, new look doesn't just mean stocking your closet, home, and makeup bag with fresh finds. We at xickle.com also took the dawning of 2017 as a cue for a major upgrade. And we did it all with you in mind.

An experience that's much more aesthetically pleasing? We've got that. A collection of articles that's easier to navigate than ever before? Yep, we've got that, too. Plus, you can now connect with us on Twitter and Facebook just by clicking the icons we've integrated into the site.

But even more importantly, our redesign calls attention to what matters to you most: How Xickle RBC-Plus will actually help sickle cell warriors like you, your family, and your friends. The new homepage, for example, greets you with important information from our recent clinical study presented last month at the American Society of Hematology's annual conference (and also published the the ASH's journal "Blood"). A study that led Dr. Peter N. Gillette -- director of the adult sickle cell program at Downstate Medical Center in New York -- to conclude that “SCD-101 [the drug equivalent of Xickle RBC-Plus] is a promising new drug for the treatment of sickle cell disease, based on the results from the studies reported here ... Clinical benefits included reduced chronic pain and fatigue, improved sleep and improved ulcer healing." The new homepage also provides a look at testimonials and gives easy access to links where you can learn more about the product, our story, and sickle cell news in general.

"We want to let people with sickle cell disease know there's hope," explains Dr. Eric Coles, Xickle's CEO.

So, what are you waiting for? Check out some of our most popular posts below and experience our new design for yourself!

A New Hope: Introducing the New and Improved Xickle RBC-Plus

Mortality Rates in Pregnant Women with Sickle Cell Slashed

Why a Warrior’s Mental Health is Just as Important as Physical Health

3 Ways to Prevent a Crisis in the Colder Months

We'd love to hear your thoughts on our new look! Hit us up via the contact form and tell us what you think.